DAMAC Properties Builds Tiger Woods Designed Golf Course In Dubai

Hussain Sajwani is a multi-billionaire businessman and entrepreneur from Dubai, United Arab Emirates. In 2002, he founded DAMAC Properties, a luxury real estate development company based in Dubai. The company quickly became one of the most sought-after residential real estate developers in the Middle East. Hussain Sajwani has worked with his friend Donald Trump, on two major Trump-branded projects in the emirate. They developed the Trump International Golf Club in Dubai and it opened in February 2017. The Trump World Golf Course is scheduled to open during the summer of 2018. The course was designed by professional golfer, Tiger Woods and will be located on the Akoya residential grounds developed by DAMAC.


The Hussain Sajwani family have remained close with the Trumps. Last year, the DAMAC owner had a luncheon with the President’s son Eric Trump and they discussed business regarding the Dubai golf courses. DAMAC Properties has completed over 19,000 residential projects across the U.A.E. and currently have 44,000 units under construction. They have developed a variety of exquisite residential projects with interior designs styled and branded by Italian luxury powerhouses: Versace, Fendi and Bugatti. DAMAC also became the first Middle Eastern real estate company publicly listed on the London Stock Exchange in December 2013. Prior to DAMAC Properties, Hussain Sajwani had launched a food catering business in 1983. They have provided food to the U.S. army camps, Middle Eastern hotels and large corporate construction campsites. His catering company is still active today and has expanded to supply other services.


In his early life, Hussain Sajwani used to help out at his father’s shop. His father was an entrepreneur who sold watches, apparel, pens and goods imported from China. He attended the University of Washington after receiving a Dubai government scholarship and earned his B.S. degree in Economics and Industrial Engineering. He used to work in the financial department at Abu Dhabi Gas Industries, formerly known as GASCO, in 1981. Today, Sajwani lives in Dubai, U.A.E., where he shares four children with his wife. He was recognized as one of the top 100 most influential Arabs by Gulf Business in 2017.


Dr. Scott Rocklage Of 5AM Ventures Becomes An Early Investor In Expansion Therapeutics

Expansion Therapeutics is a biotech startup that is seeking to complete a Series A financing round. This is the very first round of venture capital financing that a new company goes through.

They get money from either angel investors, early stage capital venture firms, or a combination of the two. Their goal is to fight a collection of genetic disorders which includes myotonic dystrophy type 1.

This genetic disorder is the main reason adults develop muscular dystrophy. They have so far raised about $53.3 million. Dr. Scott Rocklage of 5AM Ventures took part in this Series A.

There are a number of firms investing in Expansion Therapeutics. The four main venture capital firms were the aforementioned 5AM Ventures plus Novartis Venture Fund, Kleiner Perkins, and Sanofi Ventures. RA Capital Management and Alexandria Venture Investments also took a smaller role in this Series A financing round. Read more: Scott Rocklage | Bloomberg and Scott Rocklage | Crunchbase

Muscular dystrophy is believed to present itself when a person’s RNA reaches a toxic level. If the production of RNAs hit toxic levels in a person’s cells than myotonic dystrophy type 1 occurs.

At this point a number of organs and systems start to become defective such as the central nervous system, the hormonal system, the gastrointestinal system, the hearts, and muscles in general. It is a hereditary disease that is passed down through genetics. To date there is no cure for this condition.

Dr. Scott Rocklage is the managing partner at 5AM Ventures. He has years of experience in the healthcare industry as a researcher and developer, executive, and investor.

He attended the Berkeley campus of the University of California which is where he earned his chemistry degree. He then moved across the country and earned a Ph.D. in this subject at MIT.

Over the course of his professional career Dr. Scott Rocklage has published many research papers of which over 100 have been published in peer-reviewed scientific journals.

He also holds over 30 United States patents for which he either invented himself or co-invented with others. He now invests in early stage biotech startups and serves on many of these company’s board of directors.

Learn more about Scott Rocklage:


IDLife’s Unique Concept Is Making Waves In The Nutritional World

IDLife is a network marketing company that sells supplements, but these are not just any supplements; they are personalized for each customer. Individuals can take a free, confidential online assessment that asks about their diet, lifestyle, medications are more. Besides nutritional supplements, the company offers a skin care line, energy shots and a shake that may help with weight loss and joint mobility. There are all natural, mint flavored sleeping strips that contain melatonin as well.

Celebrity trainer Jennifer Widerstrom and former Dallas Cowboy’s football quarterback Troy Aikman both endorse IDLife. They know that IDLife’s products will help people reach their fitness goals. Additionally, the products are made with high quality ingredients, with no synthetic fillers. For individuals interested in losing weight, IDLife’s chocolate chews stimulate metabolism and help break down fat.

Like IDLife on Facebook

CEO Logan Stout, author of Stout Advice: The Secrets to Building Yourself, People, and Teams, ensures that independent associates have an opportunity succeed with a personalized website and other tools. He is the ideal CEO of a network marketing company since he is a highly sought after motivational speaker and mentor. There is also a program where gyms, salons and other businesses to sell IDLife’s products.

Last year, Stout announced that IDLife was partnering with wearable fitness device manufacturing company, Garmin, which IDLife will sell on the company’s website. The Vivo model fitness tracker will make it easy for IDLife’s customers to determine their nutritional requirements by syncing with the Wellness App for iOS or Android. In addition to the Wellness App, IDLife has a free IDOffice App for associates to run their business on the go.

IDLife has a Corporate Wellness Program for companies that want a healthier workforce. Companies get a personalized website where employees can get personalized recommendations for making incremental changes. IDLife offers coaching, meal plans, fitness plans and more as well.

Find more about IDLife: http://digitalmode.net/2017/07/13/founder-idlife-logan-stout-announces-exciting-partnership-garmin/

Dr. David Samadi: Mitt Romney Prognosis Good

A prostate cancer diagnosis can be worrying for anyone, but Dr. David Samadi believes former Presidential Nominee Mitt Romney made the right decision by choosing surgery instead of radiation to treat his disease. He joins politicians John Kerry and Colin Powell as they both chose surgery to remove their prostate cancer. After successfully undergoing surgery at UC Irvine Hospital, his prognosis is good according to Dr. David Samadi.

At the age of 70, Mitt Romney fits the statistic of 6 in 10 men being 65 or older at diagnosis. The average of at diagnosis is 66. 161,360 men in 2017 were diagnosed with prostate cancer according to the American Cancer Society with an estimated 164,690 diagnoses in 2018.

Dr. David Samadi makes sure to inform his patients of the pros and cons of radiation and surgery, but will almost always recommend surgery over radiation if it’s a viable option. If cancer is managed to be localized to just the prostate, surgery to remove the diseased organ can result in a nearly 100% survival rate. Radiation can cause secondary cancer, if this happens there is less than a 30% chance of survival for more than 5 years. These secondary cancers can include bladder and rectal cancer.

The creator of the Samadi Modified Advanced Robotic Treatment, or SMART, has performed well over 7,000 prostate cancer surgeries in the past decade and about 90% of these patients were cancer-free due to surgery. Also, Dr. David Samadi’s SMART system allows for much smaller incision sites making healing time shorter.

Dr. David Samadi received his education at Stony Brook University, earning his medical degree at Stony Brook School of Medicine in 1994. He received additional training in proctology and urology at the Albert Einstein College of Medicine and Montefiore medical center. Dr. Daid Samadi also completed two fellowships at Memorial Sloan Kettering Cancer Center and Henri Mondor Hospital Creteil in oncology and robotic radical prostatectomy. At Henri Mondor, he was mentored by Professor Claude Abbou.

Columbia Presbyterian Hospital in New York was the first hospital he practiced out of. He was the director of laparoscopic surgery at Presbyterian before leaving to work at Mount Sinai in 2007. When he made the move to Lenox Hill Hospital, he brought his surgical staff from Mount Sinai with him. He is currently the Chief of Robotic Surgery and the Chairman of Urology at Lenox Hill.